Fig. 1
From: Automated image analysis of NSCLC biopsies to predict response to anti-PD-L1 therapy
Digital image analysis segmentation of CD8+ and programmed cell death ligand-1 (PD-L1) + cells in single immunohistochemistry labelled sections of non-small cell lung cancer. Serial tumor sections of durvalumab-treated patients enrolled in Study 1108 were labelled separately using brown chromogen for both CD8 (a) and PD-L1 (b). Image analysis segmentations of cells expressing each marker (c and d) are shown as red and quantifications of the corresponding expression levels are performed separately